Tasisulam Sodium
N/A
Report date: 2022/07/04 19:38:02
NME
Base Information
Drug NameTasisulam Sodium
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[13]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[21]
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesEli Lilly And Company
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesEli Lilly And CompanyEli Lilly Asia Shanghai Representative Office
Active IndicationsN/A
Inactive Indications +[13]
Other Information
ATC CodeN/A
Related LinksKEGG